ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3191

Coronary Revascularization Procedure Rates and Risks Among Patients with Systemic Lupus Erythematosus Compared to Those with Diabetes Mellitus in a Nationwide Medicaid Cohort

Medha Barbhaiya1, Candace H. Feldman1, Sarah K. Chen2, Hongshu Guan3, Tzu-Chieh Lin1, Michael A. Fischer4, Daniel H. Solomon5, Brendan M. Everett6 and Karen H. Costenbader1, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Beth Israel Deaconess Medical Center, Boston, MA, 3Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Division of Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 6Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Heart disease and systemic lupus erythematosus (SLE), SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 16, 2016

Title: Health Services Research II

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose : We have recently found that myocardial infarction (MI) risk was similar among age- and sex-matched SLE patients compared to diabetes mellitus (DM) patients within a U.S. Medicaid cohort. However, little is known about rates and relative risks of coronary revascularization (CR) procedures, such as coronary artery bypass grafting (CABG) and percutaneous coronary interventions (PCI), among SLE compared to DM patients. We compared rates and relative risks of CR procedures among patients with SLE and DM enrolled in Medicaid.

Methods : We utilized Medicaid Analytic eXtract (MAX) data, containing billing claims for Medicaid patients from 29 most populated U.S. states from 2007-2010. We identified adults aged ≥18-65 years with prevalent SLE or DM (≥3 ICD-9 codes for SLE or DM, each separated by ≥30 days) and >6 months enrollment prior to 3rd code (=index date). We performed 1:2 matching (SLE:DM) by age (month/year), sex, and index date. Sociodemographic data and medical and cardiac comorbidities were collected during the baseline period (6 months prior to and including index date). Outcomes were assessed after index date, including CABG, PCI, and combined CABG or PCI. Subjects were followed to first procedure, death, Medicaid disenrollment, or end of follow-up. We used Cox sub-distribution regression models to calculate hazard ratios (HRSD) of undergoing CR procedures, accounting for the competing risk of death and adjusting for sociodemographics and cardiac and medical comorbidities.

Results : 32,089 prevalent SLE patients were matched to 64,178 prevalent DM patients. In both cohorts, 92.8% were female and mean age was 41.3 (±12.1) years. There were more Blacks (41.1 vs. 30.5%) and fewer Whites (36.3 vs 45.1%) in the SLE vs. DM cohort. Mean follow-up was 1.67 (±1.03) years for SLE and 1.79 (±1.07) years for DM. Cardiac risk factors at baseline were more prevalent among DM vs. SLE patients: hypertension (38.0 vs. 33.7%), hyperlipidemia (22.5 vs. 10.6%), and obesity (11 vs. 4.5%). PCI rates were nearly 10-fold those of CABG rates in each cohort (Table). Annual rates of CABG and PCI were much higher among SLE than DM patients. Age- and sex-adjusted risks of CR procedures, particularly CABG, were higher among SLE than DM patients. Multivariable adjustment attenuated relative risks slightly. The multivariable-adjusted HRSD for CABG was 1.83 (95%CI 1.48-2.25) and for PCI was 1.23 (95%CI 1.15-1.31) in SLE vs. matched DM patients.

Conclusion : Despite similar MI risks among SLE and DM patients, SLE patients had substantially higher rates of PCI and CABG compared to age- and sex-matched DM patients. SLE patients had > 80% increased risk of CABG compared to DM patients. While the etiology of these differences is not clear, they suggest that underlying cardiovascular disease may more severe or more likely to come to medical attention among SLE than similar age and sex DM patients. Barbhaiya_Table_PNG_submitted.png


Disclosure: M. Barbhaiya, None; C. H. Feldman, None; S. K. Chen, None; H. Guan, None; T. C. Lin, None; M. A. Fischer, None; D. H. Solomon, None; B. M. Everett, None; K. H. Costenbader, UpToDate, 7.

To cite this abstract in AMA style:

Barbhaiya M, Feldman CH, Chen SK, Guan H, Lin TC, Fischer MA, Solomon DH, Everett BM, Costenbader KH. Coronary Revascularization Procedure Rates and Risks Among Patients with Systemic Lupus Erythematosus Compared to Those with Diabetes Mellitus in a Nationwide Medicaid Cohort [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/coronary-revascularization-procedure-rates-and-risks-among-patients-with-systemic-lupus-erythematosus-compared-to-those-with-diabetes-mellitus-in-a-nationwide-medicaid-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/coronary-revascularization-procedure-rates-and-risks-among-patients-with-systemic-lupus-erythematosus-compared-to-those-with-diabetes-mellitus-in-a-nationwide-medicaid-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology